Upload
breonna-sheehan
View
215
Download
0
Embed Size (px)
Citation preview
1
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Pattern of the Incidence of Thyroid Cancer before and after Universal Salt
Iodization in Shanghai
Ying Zheng MD, MScDepartment of Cancer Control and Prevention
Shanghai Municipal Center for Disease Control and Prevention
2
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Thyroid Cancer
Risk factors Ionizing radiation
History of benign thyroid diseases
Iodine deficiency has been associated with follicular thyroid cancer
its pathogenesis is still unknown
Summarized in WHO/IARC --World Cancer Report 2008
3
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Thyroid Cancer Worldwide
141,000 new cases in 2002 worldwide Rare malignancyMore common in females than in males (M:F sex
ratio, 0.36)2.1% of cancers in womenStable or slowly increasing in most countries
Global Cancer Statistics, 2002
4
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
5
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Debate on Iodized Salt
July 31, 2009Southern Metropolis WeeklyDoubts about Iodized Salt : Over-supplement Causes Diseases?
August 13, 2009Ministry of Public Healthreplied:
Iodine Intake of Chinese Population is below the upper limit set by WHO
6
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Objectives
Describe the incidence of thyroid cancer in Shanghai;
To study the 30 years time trend in urban area;
Internationally comparison;
Provide evidences for evaluate the health effect of universal salt iodization.
7
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Methods
Data Resources: Shanghai Cancer Registry
Current pattern: Incidence by gender, age, district and histological types for the cases
diagnosed in 2002-2006
Time trend Diagnosed in the past 33 years APC (Annual Percent Change) joinpoint model
Compared with USA SEER .
8
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Results
9
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Current pattern
Crude incidence rate: 7.18 per 100 000
The ASR (W.) : 4.99 per 100 000
Ranks 6th in female, with 3.5 times higher than male
10
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Incidence of Thyroid Cancerin Shanghai in 2002-2006
Gender CasesFrequency
%Crude rate1/100,000
ASR(W.)1/100,000
TASR(35-64)
1/100,000
Cum. rate0-64
%
Cum. rate0-74
%M/I ratio
Urban and Rural
Male 1095 0.89 3.24 2.23 4.22 0.17 0.22 0.17
Female 3737 3.68 11.17 7.86 15.59 0.62 0.73 0.09
Total 4832 2.15 7.18 4.99 9.77 0.39 0.47 0.11
Urban
Male 548 0.94 3.51 2.36 4.58 0.18 0.23 0.18
Female 1764 3.35 11.49 7.78 16.19 0.63 0.74 0.10
Total 2312 2.09 7.46 5.00 10.21 0.40 0.48 0.12
Rural
Male 547 0.84 3.00 2.11 3.90 0.16 0.20 0.16
Female 1973 4.03 10.90 7.87 14.99 0.62 0.71 0.08
Total 2520 2.21 6.94 4.95 9.34 0.39 0.45 0.10
11
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Age-specific Incidence of Thyroid Cancerin Shanghai in 2002-2006
0
200
400
600
800
0- 5- 10- 15- 20- 25- 30- 35- 40- 45- 50- 55- 60- 65- 70- 75- 80- 85-
age-group
case
s
0
2
4
6
8
10
12
14
16
18
20
rate
(1/1
00,0
00)
Male cases Female cases Male rate Female rate
12
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Distribution of cases diagnosed by age groups
20.57%
20.58%
20.55%
45.05%
46.08%
41.55%
18.85%
18.22%
21.00%
0% 20% 40% 60% 80% 100%
Total
Female
Male
0-24 25-39 40-54 55-69 70+
13
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
The histological type of Thyroid cancer
Shanghai
Papillary 73.41%
Follicular 3.27%
Medullary 1.47%
World estimated
Papillary 50-80%
Follicular 10-40%
Medullary 5-15%
14
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Pattern of Incidence 2002: Comparison Internationally
0
1
2
3
4
5
6
7
0-14 15-44 45-54 55-64 65+
1/10
0,00
0
World More developed countries
Less developed countries United States of America
China Shanghai(2002-2006)
0
4
8
12
16
20
0-14 15-44 45-54 55-64 65+
1/10
0,00
0
World More developed countries
Less developed countries United States of America
China Shanghai(2002-2006)
Male Female
GLOBOCAN 2002
15
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Change of Age-specific Rate of Thyroid Cancer in Urban of Shanghai from 1973 to 2006
0
1
2
3
4
5
6
7
0- 5- 10- 15- 20- 25- 30- 35- 40- 45- 50- 55- 60- 65- 70- 75- 80-
1/10
0,00
0
1973-1977 1983-1987 1993-1997 2003-2006
0
4
8
12
16
20
24
0- 5- 10- 15- 20- 25- 30- 35- 40- 45- 50- 55- 60- 65- 70- 75- 80-
1/10
0,00
0
1973-1977 1983-1987 1993-1997 2003-2006
Male Female
16
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Trends of Incidence of Thyroid Cancer among Male in Urban of Shanghai from 1973 to 2006
Segment Period APC t P
Cruderate
1973-2006 1.92 2.83 0.01
1 1973-1983 -8.7 -4.79 0.00
2 1983-2001 3.84 4.40 0.00
3 2001-2006 20.91 3.48 0.00
ASR (W.)
1973-2006 0.98 1.46 0.15
1 1973-1984 -8.43 -5.21 0.00
2 1984-2001 3.21 3.28 0.00
3 2001-2006 19.11 3.12 0.00
2001
1984
0
1
2
3
4
5
6
1973 1976 1979 1982 1985 1988 1991 1994 1997 2000 2003 2006
1/10
0,00
0
Crude rate Observed Modelled joinpoint
ASR Observed Modelled joinpoint
17
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Trends of Incidence of Thyroid Cancer among Female in Urban of Shanghai from 1973 to 2006
Segment Period APC t P
Cruderate
1973-2006 2.61 3.72 0.00
1 1973-1985 -7.80 -7.47 0.00
2 1985-2003 6.84 10.28 0.00
3 2003-2006 25.46 2.47 0.02
ASR(W.)
1973-2006 1.81 2.6 0.01
1 1973-1984 -9.56 -8.28 0.00
2 1984-2003 5.52 9.3 0.00
3 2003-2006 25.91 2.56 0.02
2003
1984
0
2
4
6
8
10
12
14
16
18
1973 1976 1979 1982 1985 1988 1991 1994 1997 2000 2003 2006
1/10
0,00
0
Crude rate Observed Modelled joinpoint
ASR Observed Modelled joinpoint
18
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Universal Salt Iodization in China
The Act for the management of salt iodization for avoiding iodine deficiency
State Department Act No.163 P.R.C.
Signed and issued on August 23, 1994 by Premier Li Peng
Enforced began from October 1, 1994
19
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Take 1995 as a cut point
Male Seg. Period APC t P
Cruderate
1 1973-1983 -8.43 -4.06 0.00
2 1983-1995 3.22 1.92 0.07
3 1995-2001 4.03 1.70 0.13
4 2001-2006 20.29 6.02 0.00
ASR (W.)
1 1973-1983 -8.87 -4.13 0.00
2 1983-1995 1.73 1.00 0.33
3 1995-2001 3.86 1.64 0.14
4 2001-2006 18.33 5.52 0.00
Female Seg. Period APC t P
Cruderate
1 1973-1985 -8.27 -7.05 0.00
2 1985-1995 8.34 4.97 0.00
3 1995-2002 4.01 4.54 0.00
4 2001-2006 23.01 10.10 0.00
ASR (W.)
1 1973-1985 -8.97 -7.93 0.00
2 1985-1995 7.53 4.65 0.00
3 1995-2003 4.30 3.78 0.01
4 2003-2006 28.22 4.87 0.00
20
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Trends of Incidence of Thyroid Cancerin USA SEER from 1973 to 2006
1982
1993
0
2
4
6
8
10
12
14
16
18
1973 1976 1979 1982 1985 1988 1991 1994 1997 2000 2003 2006
1/10
0,00
0
Crude rate Observed Modelled joinpoint
ASR Observed Modelled joinpoint
1989
0
1
2
3
4
5
6
1973 1976 1979 1982 1985 1988 1991 1994 1997 2000 2003 2006
1/10
0,00
0
Crude rate Observed Modelled joinpoint
ASR Observed Modelled joinpoint
Male Female
21
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Comparison: Shanghai Vs. US
2001
1984
1989
0
1
2
3
4
5
6
1973 1976 1979 1982 1985 1988 1991 1994 1997 2000 2003 2006
1/10
0,00
0
上海市区 粗率 观察值 拟合值 joinpoint点
上海市区 标率 观察值 拟合值 joinpoint点
美国SEER 粗率 观察值 拟合值 joinpoint点
美国SEER 标率 观察值 拟合值 joinpoint点
Male Female
20031982
1993
1984
0
2
4
6
8
10
12
14
16
18
1973 1976 1979 1982 1985 1988 1991 1994 1997 2000 2003 2006
1/10
0,00
0
上海市区 粗率 观察值 拟合值 joinpoint点
上海市区 标率 观察值 拟合值 joinpoint点
美国SEER 粗率 观察值 拟合值 joinpoint点
美国SEER 标率 观察值 拟合值 joinpoint点
22
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Conclusions
Shanghai is among the areas with the highest incidence of thyroid cancer in the world. Compared to more developed countries.
The incidence of male is at the average levelThe incidence of female is above the average level
Continual increase in past 33 years Similar to US which has compulsory salt iodization for over 80
years Synchronous with the improvement of Ultrasonic and Biopsy
There is no solid evidence to suggest a relationship between the rise of thyroid cancer incidence and universal salt iodization
23
肿瘤防治科Dept. of Cancer
Ctr. & Prevention
Next Steps
Short term: Case-control Study
Long term: Risk Factors
Collect and analyze the long-term incidence pattern
Study on interaction on iodin exposure and other environment factors
Genetic factors